p73 in apoptosis

被引:59
|
作者
Stiewe, T [1 ]
Pützer, BM [1 ]
机构
[1] Univ Essen Gesamthsch, Sch Med, Inst Mol Biol, Ctr Canc Res & Canc Therapy, D-45122 Essen, Germany
关键词
apoptosis; p73; tumour suppressor;
D O I
10.1023/A:1012433522902
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The TP53 tumour-suppressor gene belongs to a family that includes the two recently identified homologues TP63 and TP73. Overexpression of p73 can activate typical p53-responsive genes and induce apoptosis like p53. In addition, activation of p73 has been implicated in apoptotic cell death induced by aberrant cell proliferation and some forms of DNA-damage. These data together with the localization of TP73 on chromosome 1p36, a region frequently deleted in a variety of human cancers, led to the hypothesis that p73 has tumour suppressor activity just like p53. However, despite its proapoptotic activity in vitro, the lack of tumour-formation in p73 knock-out mice and primary human tumour data demonstrating overexpression of wild-type p73 currently argue against p73 being a classical tumour suppressor. Interestingly, in contrast to TP53, TP73 gives rise to a complex pattern of pro- and antiapoptotic p73 isoforms generated by differential splicing and alternative promoter usage. Therefore further insight into the function and regulation of these structurally and functionally diverse p73 proteins is needed to elucidate the role of TP73 for apoptosis and human tumorigenesis.
引用
收藏
页码:447 / 452
页数:6
相关论文
共 50 条
  • [1] p73 in apoptosis
    T. Stiewe
    B. M. Pützer
    [J]. Apoptosis, 2001, 6 : 447 - 452
  • [2] p73 induces apoptosis by different mechanisms
    Ramadan, S
    Terrinoni, A
    Catani, MV
    Sayan, AE
    Knight, RA
    Mueller, M
    Krammer, PH
    Melino, G
    Candi, E
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (03) : 713 - 717
  • [3] p73
    Davis, PK
    Dowdy, SF
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (10): : 935 - 939
  • [4] Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53
    Igor Fillippovich
    Natasha Sorokina
    Magtouf Gatei
    Ygal Haupt
    Karen Hobson
    Eli Moallem
    Kevin Spring
    Michelle Mould
    Michael A McGuckin
    Martin F Lavin
    Kum Kum Khanna
    [J]. Oncogene, 2001, 20 : 514 - 522
  • [5] Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53
    Fillippovich, I
    Sorokina, N
    Gatei, M
    Haupt, Y
    Hobson, K
    Moallem, E
    Spring, K
    Mould, M
    McGuckin, MA
    Lavin, MF
    Khanna, KK
    [J]. ONCOGENE, 2001, 20 (04) : 514 - 522
  • [6] p73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis
    Sayan, A. E.
    Sayan, B. S.
    Gogvadze, V.
    Dinsdale, D.
    Nyman, U.
    Hansen, T. M.
    Zhivotovsky, B.
    Cohen, G. M.
    Knight, R. A.
    Melino, G.
    [J]. ONCOGENE, 2008, 27 (31) : 4363 - 4372
  • [7] p73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis
    A E Sayan
    B S Sayan
    V Gogvadze
    D Dinsdale
    U Nyman
    T M Hansen
    B Zhivotovsky
    G M Cohen
    R A Knight
    G Melino
    [J]. Oncogene, 2008, 27 : 4363 - 4372
  • [8] Ectopic expression of p73α, but not p73β, suppresses myogenic differentiation
    Li, CY
    Zhu, JY
    Wang, JYJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (03) : 2159 - 2164
  • [9] A link between p73 transcriptional activity and p73 degradation
    Wu, LQ
    Zhu, HY
    Nie, LH
    Maki, CG
    [J]. ONCOGENE, 2004, 23 (22) : 4032 - 4036
  • [10] A link between p73 transcriptional activity and p73 degradation
    Liqing Wu
    Hongyan Zhu
    Linghu Nie
    Carl G Maki
    [J]. Oncogene, 2004, 23 : 4032 - 4036